Alzheimer’s disease is the most common cause of dementia, contributing to an estimated 60 to 70 percent of all cases worldwide. It’s far ahead of every other type, though vascular dementia, Lewy body dementia, and frontotemporal dementia account for most of the remaining cases. Many people, especially those over 80, have more than one type of dementia pathology at the same time.
What Happens in the Brain With Alzheimer’s
Alzheimer’s disease involves two types of protein buildup that progressively destroy brain cells. The first is a substance called beta-amyloid, which tends to clump into sticky plaques between nerve cells. The brain has cleanup systems meant to clear this protein, but when production outpaces removal, plaques accumulate and disrupt communication between neurons.
The second, and potentially more destructive, problem involves a protein called tau. In a healthy brain, tau acts like internal scaffolding for nerve cells, stabilizing the structures that transport nutrients and signals. In Alzheimer’s, tau undergoes chemical changes that cause it to bunch into tangled clusters inside neurons. These tangles are directly lethal to the cells they form in. Wherever they appear, nerve cells die. Recent research from Stanford Medicine has found that a specific segment of the tau molecule becomes hundreds of times more prone to clumping after a particular chemical modification, and this modified form is the most common version found in the tangles of Alzheimer’s patients.
This damage typically starts in areas of the brain involved in memory, then spreads to regions controlling language, reasoning, and eventually basic body functions. The process begins years or even decades before noticeable symptoms appear.
Early Warning Signs and Progression
Alzheimer’s often starts with mild cognitive impairment, a stage where memory lapses or thinking difficulties are noticeable but don’t yet interfere significantly with daily life. Not everyone with mild cognitive impairment develops dementia, but the risk is substantial. One large analysis tracking over 3,500 people found an annual progression rate of about 15.7 percent from mild cognitive impairment to clinical dementia.
Early signs often include repeating questions, misplacing things in unusual places, difficulty following conversations or managing finances, and getting lost in familiar settings. These go beyond the occasional forgetfulness that comes with normal aging. The key difference is that Alzheimer’s-related memory loss disrupts everyday functioning and tends to worsen steadily over months.
Other Major Types of Dementia
Vascular Dementia
Vascular dementia is the second most common type. It happens when blood flow to the brain is reduced or cut off, starving neurons of oxygen and nutrients. This can result from a major stroke, a series of smaller strokes (sometimes called mini-strokes), or chronic damage to the tiny blood vessels deep in the brain’s white matter. People with high blood pressure, diabetes, or a history of stroke are at the highest risk. Unlike Alzheimer’s, which tends to worsen gradually, vascular dementia sometimes progresses in noticeable steps, with sudden declines following each vascular event and periods of relative stability in between.
Lewy Body Dementia
Lewy body dementia involves abnormal clumps of a different protein, alpha-synuclein, that build up inside neurons in areas controlling thinking, memory, and movement. Its symptoms overlap with both Alzheimer’s and Parkinson’s disease, which can make it tricky to diagnose. Visual hallucinations are a hallmark, occurring in up to 80 percent of people with the condition, often early on. Other distinctive features include dramatic fluctuations in alertness and attention throughout the day, movement problems like tremor and muscle stiffness, and vivid dream-acting during sleep. Memory problems are common but may not be the first thing people notice.
Mixed Dementia Is More Common Than Expected
Autopsy studies have revealed something important: many people with dementia don’t have just one type of brain pathology. Research from the National Institute on Aging found that mixed pathologies were present in 45 percent of people who had dementia, compared to just 14 percent of those without symptoms. The likelihood of dementia climbed sharply with the number of pathologies present, rising from 22 percent in people with no detectable brain changes to 95 percent in those with three or more types of damage. This is especially common in people over 80 and helps explain why dementia symptoms can vary so much from person to person.
Risk Factors You Can Actually Change
A 2024 report from the Lancet Commission identified 14 modifiable risk factors that, taken together, account for a meaningful share of dementia cases worldwide. These aren’t guarantees, but addressing them genuinely lowers risk:
- Cardiovascular health: High blood pressure, obesity, diabetes, high LDL cholesterol, and smoking all damage blood vessels that feed the brain.
- Sensory loss: Untreated hearing loss and vision loss are both linked to increased dementia risk, possibly because they reduce cognitive stimulation and social engagement.
- Lifestyle factors: Physical inactivity, excessive alcohol consumption (more than about 12 standard US drinks per week), and social isolation each contribute independently.
- Other factors: Less education early in life, depression, traumatic brain injury, and exposure to air pollution round out the list.
None of these cause dementia on their own. But each one nudges the brain closer to a threshold where it can no longer compensate for accumulating damage. Addressing even a few of them, particularly in midlife, can meaningfully delay or reduce the chance of developing symptoms.
How Alzheimer’s Is Diagnosed Now
Diagnosing Alzheimer’s used to rely almost entirely on clinical observation, memory tests, and brain imaging, with a definitive answer only possible after death through autopsy. That’s changing. Blood tests measuring a protein fragment called p-tau217 can now predict an Alzheimer’s diagnosis with 88 to 92 percent accuracy. This is a significant shift because it allows for earlier, more confident identification without invasive procedures like spinal taps or expensive PET scans. Earlier detection matters because it opens the door to interventions while the brain still has more capacity to benefit from them.